IMPACT Therapeutics, Inc (HKG:7630)

Hong Kong · Delayed Price · Currency is HKD

14.07

+0.14 (1.01%)

Sep 30, 2026, 4:08 PM HKT

IMPACT Therapeutics Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	118.21	38.25	33.55
Revenue Growth	-	14.02%	-
Gross Profit	107.51	36.68	31.99
Operating Income	-221.33	-233.5	-211.56
Net Income	-258	-295.92	-254.76
Earnings Per Share	-1.07	-1.29	-1.27
EPS Growth	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Chinese Mainland	83.37	20.25	-
United States of America	34.84	18	33.55
Total	118.21	38.25	33.55

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	1,065	258.53	340.19
Total Debt	4.23	5.44	6.79
Net Cash (Debt)	1,061	253.1	333.41
Net Cash Growth	-	-24.09%	-
Net Cash Per Share	4.42	1.11	1.66

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-101.67	-95.88	-81.31
Capital Expenditures	-0.43	-1.51	-1.7
Free Cash Flow	-102.1	-97.39	-83.01
Free Cash Flow Growth	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Gross Margin	90.95%	95.89%	95.36%
Operating Margin	-187.24%	-610.43%	-630.63%
Pretax Margin	-218.27%	-773.63%	-759.39%
Profit Margin	-218.27%	-773.64%	-759.40%
FCF Margin	-86.38%	-254.61%	-247.43%